ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
엔브렐 시장 규모는 최근 몇 년간 크게 성장했습니다. 2025년 168억 2,542만 달러에서 2026년에는 178억 288만 달러에 이르고, CAGR 5.8%의 성장이 전망되고 있습니다. 지난 수년간의 성장은 자가면역질환 유병률 증가, TNF 억제제의 강력한 임상적 효과, 류마티스 분야에서의 생물학적 제제 채택 확대, 생물학적 제제에 대한 급여 범위 확대, 의사들의 에타너셉트 치료에 대한 숙련도 등에 기인하는 것으로 보입니다.
엔브렐 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 220억 5,402만 달러에 이르고, CAGR은 5.5%를 나타낼 전망입니다. 예측 기간 동안의 성장 요인으로는 바이오시밀러 제품의 침투 압력 증가, 비용 효율적인 생물학적 제제 대체품에 대한 관심 증가, 신흥 헬스케어 시장 수요 증가, 전문 약국 유통망 확대, 생물학적 제제 제제 기술의 지속적인 혁신 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 바이오시밀러 경쟁의 확대, 환자 중심의 약물 전달 형태에 대한 관심 증가, 장기적 자가면역치료에 대한 수요 증가, 병용요법 접근법 확대, 생물학적 제제의 콜드체인 유통에 대한 강조 강화 등이 있습니다.
자가면역질환의 유병률 증가는 향후 몇 년 동안 엔브렐 시장의 성장을 가속할 것으로 예측됩니다. 자가면역질환은 면역체계가 잘못하여 체내 정상 세포와 조직을 공격하여 염증과 각종 장기의 손상을 유발하는 질환입니다. 자가면역질환 증가는 유전적 소인, 환경적 요인, 생활습관 및 면역기능의 변화 등의 요인과 관련이 있습니다. 자가면역질환의 유병률 증가로 류마티스 관절염, 건선성 관절염과 같은 염증성 질환 관리에 도움이 되는 엔브렐과 같은 치료법에 대한 수요가 증가하고 있습니다. 예를 들어, 관절염 및 근골격계 질환을 앓고 있는 사람들을 지원하는 호주의 자선 비영리 단체인 Arthritis Australia에 따르면, 2024년 2월 기준 2025년까지 약 56만 2,378명의 호주인이 류마티스 관절염(RA)을 앓고 있을 것으로 예측하고 있으며, 이는 이는 전체 관절염 환자의 14%에 해당합니다. 따라서 자가면역질환의 유병률 증가가 엔브렐 시장 확대를 견인하고 있습니다.
엔브렐 시장에서 사업을 전개하는 주요 기업들은 업계 내 입지를 강화하기 위해 규제 당국으로부터 의약품 승인을 획득하고 있습니다. 의약품 승인은 규제기관이 임상시험의 증거를 바탕으로 신약의 안전성, 유효성, 품질을 확인하고 판매 및 사용을 평가하고 승인하는 과정입니다. 예를 들어, 2023년 10월 미국 식품의약국(FDA)은 미국 바이오 제약사 암젠(Amgen)이 2세 이상의 활동성 청소년 건선성 관절염(JPsA)을 앓고 있는 어린이를 위한 엔브렐의 치료를 승인했다고 발표했습니다. 이번 승인은 에타너셉트의 종양괴사인자(TNF) 억제제로서의 독특한 작용을 강조하는 것으로, 건선성 관절염(PsA), 류마티스 관절염(RA), 건선을 앓고 있는 성인을 대상으로 한 광범위한 안전성 및 유효성 시험을 통해 입증된 바 있습니다. 또한, 활동성 청소년 특발성 관절염(JIA) 및 건선 소아 환자에서의 사용을 뒷받침하는 약동학(PK) 데이터도 포함되어 있습니다. 청소년 건선성 관절염(JPsA)의 권장 용량은 체중을 기준으로 주 1회 피하 주사로 투여합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 한국 시장
제17장 서유럽 시장
제18장 영국 시장
제19장 독일 시장
제20장 프랑스 시장
제21장 동유럽 시장
제22장 북미 시장
제23장 미국 시장
제24장 캐나다 시장
제25장 남미 시장
제26장 중동 시장
제27장 아프리카 시장
제28장 시장 규제 상황과 투자환경
제29장 경쟁 구도와 기업 개요
제30장 세계 시장 경쟁 벤치마킹과 대시보드
제31장 주요 인수합병(M&A)
제32장 시장 잠재력이 높은 국가, 부문, 전략
제33장 부록
LSH
영문 목차
영문목차
Enbrel, with the generic name etanercept, is a prescription medication used to manage various autoimmune disorders by suppressing the immune system. It is a biologic drug that functions by blocking tumor necrosis factor (TNF), a protein that triggers inflammation in conditions like rheumatoid arthritis and psoriasis.
The main products of Enbrel include injectable solutions, prefilled syringes, combination therapies, extended-release formulations, and biosimilars. Injectable solutions are liquid medications intended for administration via injection. They are distributed through hospital pharmacies, retail pharmacies, and online pharmacies and are used for rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, and other conditions.
Tariffs are impacting the enbrel market by increasing costs associated with imported biologic manufacturing inputs, cold-chain packaging materials, specialized syringes, and sterile filling components. North America and Europe are most affected due to reliance on cross-border biologics supply chains, while Asia-Pacific faces higher costs for biosimilar development and export activities. These tariffs contribute to elevated production and distribution expenses, influencing pricing strategies. However, they are also encouraging localized biologics manufacturing, regional fill-finish capacity expansion, and supply chain diversification to enhance long-term resilience.
The enbrel market research report is one of a series of new reports from The Business Research Company that provides enbrel market statistics, including enbrel industry global market size, regional shares, competitors with a enbrel market share, detailed enbrel market segments, market trends and opportunities, and any further data you may need to thrive in the enbrel industry. This enbrel market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The enbrel market size has grown strongly in recent years. It will grow from $16825.42 million in 2025 to $17802.88 million in 2026 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increasing prevalence of autoimmune diseases, strong clinical efficacy of tnf inhibitors, expansion of biologics adoption in rheumatology, established reimbursement coverage for biologics, physician familiarity with etanercept therapies.
The enbrel market size is expected to see strong growth in the next few years. It will grow to $22054.02 million in 2030 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to growing biosimilar penetration pressure, increasing focus on cost-effective biologic alternatives, rising demand in emerging healthcare markets, expansion of specialty pharmacy distribution, continued innovation in biologic formulations. Major trends in the forecast period include increasing adoption of biosimilar competition, rising focus on patient-centric drug delivery formats, growing demand for long-term autoimmune therapies, expansion of combination therapy approaches, enhanced emphasis on cold-chain biologic distribution.
The rising prevalence of autoimmune conditions is expected to propel the growth of the Enbrel market in the coming years. Autoimmune conditions arise when the immune system incorrectly attacks the body's healthy cells and tissues, causing inflammation and damage to various organs. The increasing occurrence of autoimmune conditions is linked to factors such as genetic predisposition, environmental triggers, and changes in lifestyle and immune system function. The growing prevalence of autoimmune conditions boosts the demand for treatments like Enbrel, which aids in managing inflammatory diseases such as rheumatoid arthritis and psoriatic arthritis. For example, in February 2024, according to Arthritis Australia, an Australia-based charitable not-for-profit organization supporting people with arthritis and musculoskeletal conditions, by 2025, around 562,378 Australians are expected to be living with rheumatoid arthritis (RA), representing 14% of the total arthritis population. Consequently, the rising prevalence of autoimmune conditions is driving the expansion of the Enbrel market.
Major companies operating in the Enbrel market are securing drug approvals from regulatory authorities to strengthen their position in the industry. Drug approval is the process through which regulatory bodies assess and authorize a new drug for sale and use, confirming its safety, efficacy, and quality based on clinical trial evidence. For example, in October 2023, Amgen Inc., a US-based biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) approved Enbrel for the treatment of children aged two and older with active juvenile psoriatic arthritis (JPsA). This approval emphasizes the distinct action of etanercept as a tumor necrosis factor blocker, demonstrated through extensive safety and efficacy studies in adults with psoriatic arthritis (PsA), rheumatoid arthritis (RA), and psoriasis. It also incorporates pharmacokinetic (PK) data supporting its use in pediatric patients with active juvenile idiopathic arthritis (JIA) and psoriasis. The recommended juvenile PsA (JPsA) dosage is based on body weight and administered via weekly subcutaneous injection.
In November 2023, Amazon Web Services Inc., a US-based cloud computing company, collaborated with Amgen Inc. to increase production capacity and deliver medications to patients more quickly worldwide. Through this collaboration, Amgen is utilizing AWS to create generative AI-based solutions aimed at speeding up the discovery, development, and manufacturing of medicines for patients with serious illnesses. Amgen Inc. is a US-based producer of Enbrel.
Major companies operating in the enbrel market are Amgen Inc.
North America was the largest region in the enbrel market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the enbrel market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the enbrel market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
The enbrel market consists of sales of monoclonal antibodies, cancer immunotherapy drugs and biosimilars. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Enbrel Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses enbrel market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for enbrel ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The enbrel market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.2.1 Increasing Adoption Of Biosimilar Competition
4.2.2 Rising Focus On Patient-Centric Drug Delivery Formats
4.2.3 Growing Demand For Long-Term Autoimmune Therapies
4.2.4 Expansion Of Combination Therapy Approaches
4.2.5 Enhanced Emphasis On Cold-Chain Biologic Distribution
5. Enbrel Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Specialty Clinics
5.3 Rheumatology Centers
5.4 Retail Pharmacies
5.5 Online Pharmacies
6. Enbrel Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Enbrel Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Enbrel PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Enbrel Market Size, Comparisons And Growth Rate Analysis
7.3. Global Enbrel Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Enbrel Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Enbrel Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Enbrel Market Segmentation
9.1. Global Enbrel Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.1. Global Enbrel Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Enbrel Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Enbrel Market
11.1. Asia-Pacific Enbrel Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Enbrel Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Enbrel Market
12.1. China Enbrel Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Enbrel Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Enbrel Market
13.1. India Enbrel Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Enbrel Market
14.1. Japan Enbrel Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Enbrel Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Enbrel Market
15.1. Australia Enbrel Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. South Korea Enbrel Market
16.1. South Korea Enbrel Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
16.2. South Korea Enbrel Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. Western Europe Enbrel Market
17.1. Western Europe Enbrel Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. Western Europe Enbrel Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. UK Enbrel Market
18.1. UK Enbrel Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. Germany Enbrel Market
19.1. Germany Enbrel Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. France Enbrel Market
20.1. France Enbrel Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. Eastern Europe Enbrel Market
21.1. Eastern Europe Enbrel Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
21.2. Eastern Europe Enbrel Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. North America Enbrel Market
22.1. North America Enbrel Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
22.2. North America Enbrel Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. USA Enbrel Market
23.1. USA Enbrel Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
23.2. USA Enbrel Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Canada Enbrel Market
24.1. Canada Enbrel Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
24.2. Canada Enbrel Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. South America Enbrel Market
25.1. South America Enbrel Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
25.2. South America Enbrel Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Middle East Enbrel Market
26.1. Middle East Enbrel Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Middle East Enbrel Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Africa Enbrel Market
27.1. Africa Enbrel Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
27.2. Africa Enbrel Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. Enbrel Market Regulatory and Investment Landscape
29. Enbrel Market Competitive Landscape And Company Profiles
29.1. Enbrel Market Competitive Landscape And Market Share 2024
29.1.1. Top 10 Companies (Ranked by revenue/share)
29.2. Enbrel Market - Company Scoring Matrix
29.2.1. Market Revenues
29.2.2. Product Innovation Score
29.2.3. Brand Recognition
29.3. Enbrel Market Company Profiles
29.3.1. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
30. Global Enbrel Market Competitive Benchmarking And Dashboard
31. Key Mergers And Acquisitions In The Enbrel Market
32. Enbrel Market High Potential Countries, Segments and Strategies
32.1 Enbrel Market In 2030 - Countries Offering Most New Opportunities
32.2 Enbrel Market In 2030 - Segments Offering Most New Opportunities
